[miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3].

Xuejun Guo(Nanfang Hospital), Dehua Wu(Nanfang Hospital), Li Liu(National Clinical Research Center for Digestive Diseases), Dongyan Zhang(Shandong University), Jingyuan Sun(Nanfang Hospital), Chuanhui Cao(Ganzhou People's Hospital)

PubMed

October 1, 2014

Cited by 4

Related Papers

The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells

|Gastroenterology|2014|231

ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

|Journal for ImmunoTherapy of Cancer|2020|225

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

|European Radiology|2019|219

miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1

|Oncogene|2018|142

SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma

|Tumor Biology|2015|99